16 results
10-K
2023 FY
ADCT
Adc Therapeutics SA
13 Mar 24
Annual report
12:25pm
which may limit or ability to recruit and enroll new subjects;
difficulties in retaining and following up with subjects and censoring of patients
10-K
2023 FY
EX-10.23
ADCT
Adc Therapeutics SA
13 Mar 24
Annual report
12:25pm
and irreparable harm to the Company. I agree and covenant not to directly or indirectly solicit, hire, recruit, or attempt to solicit, hire, or recruit
6-K
ADCT
Adc Therapeutics SA
1 Jun 21
Current report (foreign)
4:42pm
a sales force is expensive and time-consuming and could delay product launch. If the commercial launch of a product candidate for which we recruit … . We must also compete with other biotechnology companies to recruit, hire, train and retain marketing and sales personnel.
Factors that may inhibit
20-F
2020 FY
ADCT
Adc Therapeutics SA
18 Mar 21
Annual report (foreign)
7:12am
is expensive and time-consuming and could delay any product launch. If the commercial launch of a product candidate for which we recruit a sales force … compete with other biotechnology companies to recruit, hire, train and retain marketing and sales personnel.
Alternatively, we may wish to establish
424B4
8lswi15l4djia
25 Sep 20
Prospectus supplement with pricing info
4:14pm
F-1
o2xw5 k1hg5p4f2z3
21 Sep 20
Registration statement (foreign)
4:30pm
DRS
npzlyp ub17opj52sn2
11 Sep 20
Draft registration statement
12:00am
424B4
cjcn7aclv237ig e1x
18 May 20
Prospectus supplement with pricing info
8:52am
F-1/A
49yh0
14 May 20
Registration statement (foreign) (amended)
6:08am
F-1/A
o9nhzwbz
11 May 20
Registration statement (foreign) (amended)
6:26am
F-1
4nmn1jfnvh20 dfua2
24 Apr 20
Registration statement (foreign)
5:23pm
DRS
asyp 3rrk4xpgh5pca
2 Mar 20
Draft registration statement
12:00am
F-1/A
ur1rp32 0j1u
23 Sep 19
Registration statement (foreign) (amended)
6:08am
F-1
c7l ioig0t8
6 Sep 19
Registration statement (foreign)
5:12pm
DRS
e9a15le
28 Jun 19
Draft registration statement
12:00am
- Prev
- 1
- Next